Share This Article

In biospecimen research, quality isn’t a feature—it’s the foundation.

Quality control (QC) ensures that biological samples maintain their integrity from collection through processing, storage, and distribution. For researchers, that consistency directly impacts data reliability, reproducibility, and ultimately, the success of downstream studies.

For organizations supporting biopharma and clinical research, QC is not just a technical requirement—it’s a strategic capability.

Why Quality Control Matters

High-quality biospecimens are essential for:

  • Reliable experimental outcomes
  • Reproducible data across studies and sites
  • Regulatory and ethical compliance
  • Confidence from research partners and stakeholders

Without rigorous QC, variability introduced at any stage—collection, handling, or storage—can compromise entire studies.

Quality Management Systems: Turning QC into a Discipline

Effective QC starts with a structured Quality Management System (QMS) that defines:

  • Standardized procedures and protocols
  • Roles and accountability across teams
  • Documentation and traceability
  • Continuous monitoring and improvement

Leading biorepositories align with internationally recognized standards such as:

  • ISO 9001 (Quality Management Systems)
  • ISO 17025 (Testing and calibration laboratories)
  • ISO 15189 (Medical laboratories)
  • ISO/TC 276 (Biotechnology)

A well-implemented QMS does more than ensure compliance—it signals operational maturity and builds trust with partners.

Building an Effective QC Program

A strong QC program goes beyond checklists. It requires a culture of discipline, transparency, and continuous improvement.

Key considerations include:

Continuous Improvement

QC processes must be continuously evaluated and refined based on performance data, audits, and feedback. Organizations that invest in improvement are better positioned to adopt new technologies and scale effectively.

Ethical Responsibility

Biospecimens originate from donors. Maintaining privacy, obtaining informed consent, and safeguarding sample integrity are essential—not optional.

Stakeholder Communication

Clear communication with researchers, regulators, and partners builds trust and ensures expectations around sample quality and handling are aligned.

Future Readiness

QC programs must evolve alongside advances in biotechnology, supporting new research modalities, increased data requirements, and more complex study designs.

The Three Stages of Quality Control

QC in biobanking spans the full lifecycle of a specimen:

1) Pre-Analytical QC

Focuses on everything before processing:

  • Proper labeling and documentation
  • Controlled handling and transport
  • Minimizing variability (e.g., ischemia time, temperature exposure)

Why it matters: Most variability is introduced at this stage.


2) Analytical QC

Applies during processing and storage:

  • Standardized protocols
  • Equipment calibration and validation
  • Environmental monitoring

Why it matters: Ensures consistency across batches, sites, and studies.


3) Post-Analytical QC

Occurs after storage, prior to distribution:

  • Sample quality assessment (e.g., DNA/RNA integrity)
  • Stability and purity checks
  • Ongoing quality assurance and improvement

Why it matters: Confirms the sample meets study requirements before use.

Core QC Procedures in Practice

High-performing biorepositories rely on a combination of structured processes and verification steps:

  • Standard Operating Procedures (SOPs): Ensure consistency across all workflows
  • Training Programs: Align teams on protocols and reduce variability
  • Monitoring & Audits: Identify issues early through inspection and testing
  • Corrective Actions: Rapidly resolve deviations and prevent recurrence

Common validation methods include:

  • Visual inspection for integrity and contamination
  • Cell counts to confirm usability
  • DNA/RNA analysis for identity and purity
  • Biomarker testing to assess sample quality and research relevance

How ABS Bio Approaches Quality

At ABS Bio, quality control is embedded across the entire biospecimen lifecycle—not applied as a final checkpoint.

Our approach emphasizes:

  • End-to-end process control from procurement through delivery
  • Standardized, repeatable workflows designed for consistency
  • Rigorous sample validation aligned with study requirements
  • Operational reliability that researchers can depend on

This integrated model helps ensure that every sample delivered is fit for purpose—supporting more confident decision-making in research and development.

Conclusion

Quality control is not a static process—it’s a continuous commitment.

As research becomes more complex and data expectations increase, the importance of QC will only grow. Organizations that invest in disciplined, well-integrated quality systems are better positioned to deliver reliable biospecimens—and to support meaningful scientific progress.

FAQ

What is quality control in human biospecimen management?
Quality control in biospecimen management refers to the processes used to ensure biological samples maintain their integrity, identity, and usability throughout collection, processing, storage, and distribution.

Why is quality control important for human biospecimens?
Quality control helps ensure reliable research results, reproducible data, regulatory compliance, and confidence in study outcomes.

What are the three stages of biospecimen quality control?
The three stages are pre-analytical quality control, analytical quality control, and post-analytical quality control.

How do biorepositories ensure biospecimen quality?
Biorepositories use standardized operating procedures, staff training, equipment validation, environmental monitoring, audits, and sample testing to maintain quality.

What standards support biospecimen quality management?
Common standards include ISO 9001, ISO 17025, ISO 15189, and ISO/TC 276 biotechnology guidelines.

Published On: June 23, 2026

HARMINDER SINGH, M.D.

Business Development Director, ABS Bio

15+ years in life sciences

Biospecimen operations expert

Precision medicine research

Harminder Singh, M.D. is Business Development Director at ABS Bio. He joined ABS Bio from Cureline, where he was instrumental in leading biospecimen operations. He brings more than 15 years of experience in the life sciences industry and is a recognized expert in human biospecimen sourcing, management, and global clinical research. Dr. Singh is actively engaged in designing and executing research projects involving human biospecimens to help develop precision medicine therapies. He has a strong track record of building and maintaining long-term partnerships with clinical networks and pharmaceutical/biotechnology clients.